At the same time, a HER2 CAR-T cells treatment administered to 2 pancreatic cancer patients, after a nab-paclitaxel-based chemotherapy, did show grade 3 toxicities, including febrile syndrome and upper gastrointestinal hemorrhage [171]. The gene discussed is ERBB2; the disease is pancreatic neoplasm.